SAN FRANCISCO, May 07, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2020. First […]
Tag: iRhythm
iRhythm Supports Cardiac Patients During the COVID-19 Crisis, While Keeping Clinicians Safe, Through Zio Virtual Platform
Zio virtual platform reduces COVID-19 spread by monitoring higher risk patients at home New program with severely ill COVID-19 patients rolled out at three New York City hospitals within Montefiore Health System SAN FRANCISCO, April 29, 2020 (GLOBE NEWSWIRE) — […]
iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors
SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April […]
iRhythm Technologies Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Financial Outlook
SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December […]
iRhythm Technologies Files Quarterly Report on Form 10-Q for Third Quarter 2019 and Updates Guidance for Full Year 2019
SAN FRANCISCO, Dec. 23, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the filing of its Quarterly Report on Form 10-Q for the period […]
iRhythm Announces Participation in GUARD-AF Study Focused on Undiagnosed Atrial Fibrillation
SAN FRANCISCO, Dec. 16, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) today announced its participation in a new, randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals), sponsored by the Bristol-Myers Squibb-Pfizer Alliance (the Alliance). […]
iRhythm Technologies Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) announced today that it received a standard notification letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated November 14, 2019, stating that, as a result of […]
Lost Money in iRhythm Technologies, Inc.?
Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.–(BUSINESS WIRE)–iRhythm Technologies, Inc. shares fell sharply after the company filed a Notification of Late Filing with the Securities and Exchange Commission (SEC) for its Quarterly Report and revealed that it […]
iRhythm Technologies Announces Third Quarter 2019 Financial Results
SAN FRANCISCO, Nov. 05, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ending September 30, 2019. Third Quarter […]
iRhythm Technologies Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the closing of its underwritten public offering of 1,575,342 shares of […]
Recent
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Popular
- No commented posts yet